Researchers have identified cellular factors that regulate the delivery and stability of mRNA to expand the potential of mRNA ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

A new study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable ...

Researchers developed a manufacturing technique that rapidly generates large quantities of nanoparticles coated with drug-delivering polymers, which hold great potential for treating cancer. The ...

Ethris, a clinical-stage biotechnology company creating RNA therapeutics and vaccines, and Lonza entered a collaboration to ...

A study conducted by researchers at Hokkaido University has unveiled a novel class of zwitterionic phospholipids capable of ...

Sunshine Biopharma's K1.1 mRNA-LNP shows promise for HCC treatment in mice, while its 2024 revenue surged 45% to $34.9 ...

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) ("We", "Our", the "Company"), a ...

Biopharma makes the NASDAQ top percentage gainers list today on news, currently trading at $2.9008,, up 0.8108.gaining ...

Sunshine Biopharma (SBFM) has completed additional studies on orthotopic human tumor models in mice confirming its K1.1 mRNA Lipid ...

Spray-drying represents a well-established technique that addresses solubility and other manufacturing and stability challenges.

A breakthrough in safely delivering therapeutic DNA to cells using lipid nanoparticles could transform treatment for millions ...